Our services

Advance your compounds to the clinic with confidence

We are seasoned specialists in chronic pain and neurodegenerative disease drug discovery with a deep understanding for Client needs. We have a proven track record of developing customer specific solutions for our Clients to ensure project progress.
Read more arrow_forward
equalizer

We deliver high quality information

We’re not just providing data, we provide valuable information and clear answers to complex biological questions.
fast_forward

We accelerate your decision-making

Thanks to our highly experienced team, proprietary discovery platform and streamlined operations, we can shorten your project lead times.
grid_on

Fast access to ground-breaking assays

We develop highly innovative in vitro assays based on complex biology that provide translationally relevant information.

WORKING WITH US

An approach you can trust

We provide fully collaborative support, tailored to each individual study. Our Clients value our interactive and open communication style, our high capacity, quality and delivery precision needed for projects from target discovery and screening to lead optimization.

Read more

Our platform

Our unique discovery platform

Our team of highly experienced neurobiologists, stem cell researchers and engineers, has developed a unique and patent protected discovery platform which enables development of innovative in vitro assays of enhanced translational value.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news, newsletters and to learn about upcoming events.

Read more

Events
December 6, 2018. 11 am EST
Webinar - Development of a novel assay platform for functional neuronal in vitro modelling of Tau pathology
Webinar Description: The progressive deposition of misfolded Tau protein is a pathological hallmark of several neurodegenerative diseases, collectively called tauopathies,...
News
2018-10-24
Cellectricon announces new opportunity for the discovery of highly differentiated therapeutics for neurodegenerative diseases
Launch of novel, high throughput in vitro platform will help researchers find molecules that can prevent prion-like spreading of neurodegenerative...
Events
November 3-7, 2018
Neuroscience 2018
Cellectricon would like to thank for all the rewarding scientific interactions at the recent Neuroscience 2018 meeting.  Especially, we appreciate...
News
2018-07-13
Henrik Zetterberg joins Cellectricon's advisory board
Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and CNS...
Events
October 4-5, 2018
4th Annual Neuroscience R&D Technologies Conference
The conference focused on discussing the latest technologies in the preclinical, translational neuroscience space and also new innovations happening in...
Newsletters
2018-09-12
September 2018
News
2017-12-19
Cellectricon strengthens Scientific Advisory Board
To further enhance Cellectricon’s expertise in Chronic Pain drug discovery, the company is today announcing the addition of another highly...
Events
March 26-31, 2019
AD/PD 2019
AD/PD™ 2019, the 14th​ International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Lisbon, Portugal on...

Get the latest news & events – sign up for our newsletter

Read about our Privacy Policy